Probiotic ; Weight loss ; Fat mass ; Lp-PLA2 ; CT ; DEXA
Abstract
Solid organ transplantation is a therapeutic option for end-stage organ diseases. However, complications including infection and
graft rejection, which are related to immunosuppressive therapy, remain the major causes of morbidity and mortality following
solid organ transplantation. The optimal approach to infection in solid organ transplant recipients is prevention; failing this, prompt
and aggressive diagnosis and therapy are essential. In addition, the epidemiology of infections after solid organ transplantation
has shifted as a result of changes in immunosuppressive strategies and improved survival. Immunosuppression must be linked
with appropriate vaccinations, donor and recipient screening, patient education regarding infectious risks and lifestyle, monitoring,
and antimicrobial prophylaxis.